PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperuricemia |
| Phenotype | C0022658|kidney disease |
| Sentences | 16 |
| PubMedID- 21547469 | hyperuricemia is associated with chronic kidney disease, arterial hypertension, coronary artery and heart disease, cerebrovascular disease and diabetes mellitus. |
| PubMedID- 24152124 | Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease. |
| PubMedID- 24877124 | However, the pathologic role of hyperuricemia in kidney disease by a crystal-independent mechanism is somewhat less clear. |
| PubMedID- 25210423 | Febuxostat for hyperuricemia in patients with advanced chronic kidney disease. |
| PubMedID- 26414732 | hyperuricemia is associated with hypertension, kidney disease, vascular and cardiovascular (cv) events. |
| PubMedID- 22948067 | Gender difference in the association of hyperuricemia with chronic kidney disease in southern china. |
| PubMedID- 26527953 | Uric acid (ua) is a powerful chemical antioxidant present in human plasma despite its physiological intention, hyperuricemia is strongly associated with cardiovascular disease, kidney disease, and hypertension, increasing the risk of mortality [10]. |
| PubMedID- 23621557 | Objectives: in this article, the results of clinical and experimental studies that examine the association of hyperuricemia and gout with hypertension and kidney disease are presented and discussed. |
| PubMedID- 26297226 | In the multivariable cox proportional hazard analyses after adjustment for several confounding factors including chronic kidney disease and use of diuretics, hyperuricemia was an independent predictor of all-cause mortality (hazard ratio 1.98, 95% confidence interval 1.036-3.793, p = 0.039). |
| PubMedID- 25685556 | Although hyperuricemia is common in patients with chronic kidney disease, the impact of uric acid on mortality and cv events remains unclear. |
| PubMedID- 21722384 | Background: hyperuricemia is prevalent in patients with chronic kidney disease (ckd). |
| PubMedID- 23960345 | This is a retrospective cohort study in chronic kidney disease (ckd) patients with hyperuricemia from 1998 to 2008. |
| PubMedID- 23058478 | Recent observational studies have associated hyperuricemia with kidney disease. |
| PubMedID- 24433285 | The feather (febuxostat versus placebo randomized controlled trial regarding reduced renal function in patients with hyperuricemia complicated by chronic kidney disease stage 3) study is a prospective, multicenter, double-blind, randomized, placebo-controlled trial of febuxostat—a novel, nonpurine, selective, xanthine oxidase inhibitor. |
| PubMedID- 21694941 | Other factors that may contribute to the relatively low rate of hyperuricemia and gout in patients with chronic kidney disease (ckd) include lower protein intake and increased intestinal clearance of uric acid. |
| PubMedID- 21783292 | Background: hyperuricemia is common in patients with chronic kidney disease (ckd). |
Page: 1